N

Nitin Mehrotra

Center for Drug Evaluation and Research

ORCID: 0000-0002-9415-2720

111 papers and 3.4k citations.

PubIndex Score93Top 7%How it's scored

111Publications

3.4kTotal Citations

First senior author: 1991

Top publicationsby citations

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Patricia Cortazar, Gideon M. Blumenthal et al.|Clinical Cancer Research|2014

Cited by 350

Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary

Yang‐Min Ning, Richard Pazdur, William F. Pierce et al.|Clinical Cancer Research|2013

Cited by 67

Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer

J Wang, Atiqur Rahman, Pengfei Song et al.|Clinical Pharmacology & Therapeutics|2014

Cited by 65

Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary

Paul G. Kluetz, Richard Pazdur, Yang‐Min Ning et al.|Clinical Cancer Research|2013

Cited by 62

Esomeprazole FDA Approval in Children With GERD

Justin Earp, Christine Garnett, Jan‐Stefan Van der Walt et al.|Journal of Pediatric Gastroenterology and Nutrition|2016

Cited by 14

Indexing the rest of 111 publications…